SABER Study for Selected Early Stage Breast Cancer

The purpose of this study is to find the most effective dose of radiation therapy to give to breast tumors in a shorter period of time, prior to standard partial mastectomy/axillary surgery.

Trial Details

NCT ID
NCT04360330
Phase
NA
Sponsor
University of Miami
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Stereotactic Ablative Breast Radiotherapy
Locations (sample)
  • Miami, Florida, United States|25.77427,-80.19366

Key Eligibility Criteria

  • Female, ≥ 50 years of age.
  • Oncotype or MammaPrint diagnosis results are required prior to the start of treatment
  • Histologically confirmed invasive breast cancer.
  • Clinical stage T1N0M0.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →